tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Aurinia Pharmaceuticals (AUPH) Revenue

Compare
2,104 Followers

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 73.47M in the quarter ending Sep 30, 2025, with 4.94%. This bring the company's revenue in the last twelve months to 265.81M, Decreased 2.19%. In the fiscal year ending Dec 31, 2024, Aurinia Pharmaceuticals had annual revenue of 235.13M with 33.97% growth.
Revenue (ttm)
265.81M
Revenue Growth
20.62%
P/S Ratio
8.76
Revenue/Employee
$1,808,715
Employees
130
Market Cap
$2.06B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
235.13M59.62M+133.97%
Dec 31, 2023
175.51M41.48M+130.95%
Dec 31, 2022
134.03M88.42M+293.89%
Dec 31, 2021
45.60M-4.51M+91.00%
Dec 31, 2020
50.12M49.80M+15,760.43%
Dec 31, 2019
318.00K-145.00K+68.68%
Dec 31, 2018
463.00K43.00K+110.24%
Dec 31, 2017
420.00K247.00K+242.78%
Dec 31, 2016
173.00K